文献速递内脏/肾动脉与血管畸形

自发性孤立性腹腔干和肠系膜上动脉夹层的系统评价与荟萃分析

Systematic review and meta-analysis of current evidence in spontaneous isolated celiac and superior mesenteric artery dissection.
PubMed 文献 · J Vasc Surg · 2018-08-17

该系统评价纳入43项研究,分析自发性孤立性腹腔干动脉夹层(SICAD)与肠系膜上动脉夹层(SISMAD)的保守治疗结局。无症状患者保守治疗安全,有症状患者后期二次干预率较高,SICAD完全重塑率高于SISMAD。

要点

  • 无症状SICAD或SISMAD患者初始保守治疗安全,无需二次干预。
  • 有症状保守治疗者二次干预率SICAD 8%、SISMAD 12%。
  • SICAD完全重塑率64%高于SISMAD的25%,SISMAD需更密切监测。

核心结论

  • 无症状SICAD或SISMAD患者初始保守治疗是安全的。
  • 有症状保守治疗患者晚期二次干预发生率相对较高,可能需要更密切监测,尤其SISMAD因重塑率较低。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、Embase、Scopus和Cochrane数据库(1946年1月1日至2017年9月21日)。
  • 纳入样本量大于10的队列研究或病例系列,共43项研究。
  • 采用随机效应模型计算合并估计值。

主要发现

  • 有症状SICAD保守治疗者随访期间需二次干预的合并估计为8%(95%CI 0.01-0.21),有症状SISMAD为12%(95%CI 0.06-0.19);无症状保守治疗者均无需二次干预。
  • 随访形态学变化:SICAD完全重塑比例64%(95%CI 0.47-0.80),高于SISMAD的25%(95%CI 0.19-0.32);形态学进展SICAD估计6%(95%CI 0.00-0.16),SISMAD为12%(95%CI 0.05-0.20)。
  • 长期全因死亡率合并估计SICAD为0%(95%CI 0.00-0.03),SISMAD为1%(95%CI 0.00-0.02)。
  • 按症状分层,有症状患者实现完全重塑的概率显著高于无症状患者(OR 3.95;95%CI 1.31-11.85)。

临床怎么用

  • 无症状SICAD或SISMAD患者初始保守治疗是安全的。
  • 有症状保守治疗患者晚期二次干预发生率相对较高,可能需要更密切监测,尤其SISMAD因重塑率较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spontaneous isolated celiac artery dissection (SICAD) and spontaneous isolated superior mesenteric artery dissection (SISMAD) represent the major types of spontaneous visceral artery dissection. However, no quantitative meta-analysis of SICAD and SISMAD is available. The aim of our study was to pool current evidence concerning basic profiles, treatment strategies, long-term adverse events, and morphologic changes of lesioned vessels in SICAD and SISMAD patients. METHODS: We searched the MEDLINE, Embase, Scopus, and Cochrane Databases (January 1, 1946-September 21, 2017) for studies of SICAD and SISMAD. Related cohort studies or case series with sample size larger than 10 were included. Two reviewers independently extracted and summarized the data. A random-effects model was used to calculate pooled estimates. RESULTS: In total, 43 studies were included. An estimated 8% (95% confidence interval [CI], 0.01-0.21) symptomatic SICAD and 12% (95% CI, 0.06-0.19) symptomatic SISMAD patients with initial conservative management required secondary intervention during follow-up, whereas none of the asymptomatic patients treated conservatively required secondary intervention. As for morphologic changes during follow-up, a higher proportion of SICAD patients (64%; 95% CI, 0.47-0.80) achieved complete remodeling compared with SISMAD patients (25%; 95% CI, 0.19-0.32), and an estimated 6% (95% CI, 0.00-0.16) of SICAD and 12% (95% CI, 0.05-0.20) of SISMAD patients had morphologic progression. Overall, the pooled estimate of long-term all-cause mortality was 0% (95% CI, 0.00-0.03) in SICAD and 1% (95% CI, 0.00-0.02) in SISMAD. When stratified by symptoms, symptomatic patients were associated with a significantly increased probability of accomplishing complete remodeling (odds ratio, 3.95; 95% CI, 1.31-11.85) compared with asymptomatic patients. CONCLUSIONS: Initial conservative treatment is safe for asymptomatic SICAD or SISMAD patients. Symptomatic patients managed conservatively have relatively high occurrence of late secondary intervention, which may require closer surveillance, especially in SISMAD because of a lower rate of remodeling.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang J, He Y, Zhao J, et al. Systematic review and meta-analysis of current evidence in spontaneous isolated celiac and superior mesenteric artery dissection. J Vasc Surg. 2018. PMID: 30126785. doi:10.1016/j.jvs.2018.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。